Endo International Plc
(NASDAQ : ENDP)

( )
ENDP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. 0.27%53.000.0%$620.28m
CTLTCatalent, Inc. -0.08%135.982.0%$167.28m
VRXValeant Pharmaceuticals International, Inc. 0.00%28.2114.1%$165.99m
PRGOPerrigo Co. Plc 0.68%43.036.9%$139.81m
ICLRICON plc 0.00%269.962.8%$115.50m
HZNPHorizon Therapeutics Plc 0.00%109.765.5%$105.41m
JAZZJazz Pharmaceuticals Plc 0.00%129.102.1%$95.77m
INDPIndaptus Therapeutics, Inc. 0.85%8.340.0%$93.78m
ARGXargenx SE -1.37%312.050.0%$67.41m
BHCBausch Health Cos., Inc. 0.00%28.210.0%$57.35m
AXSMAxsome Therapeutics, Inc. 2.34%31.941.8%$55.32m
UTHRUnited Therapeutics Corp. 0.00%198.8314.0%$49.03m
ENDPEndo International Plc -0.36%2.758.5%$48.70m
SAGESAGE Therapeutics, Inc. 0.00%45.237.6%$21.01m
IRWDIronwood Pharmaceuticals, Inc. 0.00%12.679.5%$20.95m

Company Profile

Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The firm operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment conducts certain manufacturing, quality assurance, R&D and administration functions. The Generic Pharmaceuticals segment conducts certain manufacturing, distribution, quality assurance and administration functions, as well as certain R&D functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland.